Pyrexia, commonly known as fever, is a clinical symptom frequently encountered in medical practice. It is a physiological response to a variety of conditions, most commonly infectious diseases. Understanding the pathophysiology, identifying the cause, and managing fever effectively are critical to patient care.
Pyrexia is the body's adaptive response to pathologic conditions, primarily infections. The hypothalamus, acting as the body's thermostat, raises the set-point temperature in response to pyrogens. These can be endogenous, such as cytokines, or exogenous like microbial toxins. This results in the characteristic symptoms of fever.
Identifying the cause of pyrexia is crucial for targeted treatment. A detailed history and physical examination often provide valuable clues. Laboratory tests, including complete blood count, cultures, and imaging studies, may be necessary in some cases. Infections are the most common cause, but non-infectious causes such as malignancies, autoimmune diseases, and drug reactions should also be considered.
Management of pyrexia involves treating the underlying cause and symptomatic relief. Antipyretics, such as paracetamol and non-steroidal anti-inflammatory drugs, are commonly used for symptomatic relief. However, their use should be balanced against potential side effects. In cases where the cause of fever is unclear, empirical antimicrobial therapy may be initiated while investigations are ongoing.
Management of pyrexia may differ in special populations, such as children, pregnant women, and immunocompromised patients. In these groups, the risk of serious infections is higher, and a more cautious approach is often warranted. Additionally, the choice of antipyretics may be limited due to safety concerns.
Pyrexia is a common clinical symptom with a wide range of causes. A systematic approach to identifying the cause and managing the fever effectively is essential. Further research is needed to refine our understanding of the pathophysiology of fever and to develop more effective antipyretic therapies.
1.
Global warming could be driving up women's cancer risk, find researchers
2.
Blood tests can predict the risk of relapse after a bone marrow transplant in patients with acute myeloid leukemia.
3.
Survey shows cancer anxiety has impact well beyond the individual diagnosed
4.
MRI can save rectal cancer patients from surgery, study suggests
5.
Glioma Outcomes Shaped by Subtype More Than Tx Sequence
1.
Rehabilitation After Organ-Conserving Cancer Surgery
2.
Practical Breakthroughs in Oncology Across Clinical Settings
3.
Gynecologic Oncology: Advances, Education, and Clinical Excellence
4.
Breaking Down the Different Types of Lymphoma: What You Need to Know
5.
RNA-Targeting Chimeras in Cancer: Mechanisms, Clinical Advances, and Future Directions
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part II
2.
First Line Combination Therapy- The Overall Survival Data in NSCLC Patients
3.
Cancer Care: From Awareness to Recovery
4.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VII
5.
A Conclusive Discussion on CROWN Trial and the Dawn of a New Era in Frontline Management of ALK+ NSCLC
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation